Group 1 - The company is building a three-dimensional research and innovation system focusing on short, medium, and long-term goals, actively introducing quality projects and innovative technologies in the short to medium term [1] - The technology center continues to conduct research on new drug imitation and innovation, enhancing the company's product portfolio and competitiveness in specific fields [1] - The company is advancing the development of innovative technologies and products such as nano carbon iron in the long term, and is promoting the independent research and development of cell immunotherapy and personalized innovative medical technologies by its affiliate [1] Group 2 - In the reporting period, the company obtained approvals or supplementary application approvals for various products, including Clindamycin Phosphate Injection and Naloxone Hydrochloride Injection, and passed consistency evaluations [1] - The company’s product Esomeprazole Magnesium Enteric-coated Capsules and others were selected for provincial centralized procurement projects, enhancing market share [1] - Laimei Pharmaceutical reported a revenue of 377 million yuan for the first half of 2025, focusing on consolidating the leading position of its flagship product, Kanalin, in its niche market [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 05月21日，昔日牛市"大明星"金固股份再获全球顶级车企10年长单，固态电池概念企业上海洗霸重金购 入中科院核心专利，知名金企四川黄金突遭两大股东减持…… 以下是盘后公告精选： 金固股份：收到全球龙头车企美国产乘用车车轮产品定点通知 金固股份晚间发布公告，公司收到某全球龙头车企的定点通知书，将为其美国产乘用车开发车轮产品， 项目生命周期10年，预计2026年开始量产，前五年销售金额预计约1.58亿美元。这是公司在美国本土获 得的第二个乘用车OE项目，此前已进入该客户全球供应链体系，并批量供货。项目计划明年下半年量 产，预计对本年度收入及利润水平无重大影响。但定点通知不反映实际采购量，预计销售金额存在不确 定性。量产时间和实际供货量受多种因素影响。 上海洗霸：购买专利资产及设立控股子公司 上海洗霸公告，公司拟以2000万元购买中国科学院大连化学物理研究所的3项发明专利和1项实用新型专 利的专利权；同时，以500万元购买2项发明专利的专利权。公司计划与核心技术团队、管理团队合资设 立2家控股子公司，注册资本均为1000万元，以推动相关技术的产业化发展。此次交易不构 ...